Literature DB >> 18002956

Diffusion tensor MR study of optic nerve degeneration in glaucoma.

Edward S Hui1, Qing-ling Fu, Kwok-fai So, Ed X Wu.   

Abstract

Axonal degeneration has been known to occur in the optic nerve (ON) of rat glaucoma model. Recently, quantitative diffusion tensor imaging (DTI) has been developed to investigate various white matter diseases in vivo. In this study, longitudinal DTI was thus employed to study such animal model in the present study. The results showed that radial diffusivity (lambda) and fractional anisotropy (FA) of the glaucomatous ON (gON) was increasing and decreasing respectively with time after glaucoma induction, whereas there was no significant change in the axial diffusivity (lambda//). Supported by the histological staining of the ON, such changes in the two DTI-derived parameters were attributed to the 10% decrease in the axonal density of the gON as compared to nON. It was shown for the first time that DTI can be sensitive enough to detect axonal degeneration in rat glaucoma model. DTI therefore holds promise for reliable diagnoses and assessment of the glaucoma disease in human upon careful interpretation of the DTI-derived directional diffusivities.

Entities:  

Mesh:

Year:  2007        PMID: 18002956     DOI: 10.1109/IEMBS.2007.4353290

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  19 in total

1.  Graph theoretical analysis reveals the reorganization of the brain network pattern in primary open angle glaucoma patients.

Authors:  Jieqiong Wang; Ting Li; Ningli Wang; Junfang Xian; Huiguang He
Journal:  Eur Radiol       Date:  2016-02-11       Impact factor: 5.315

2.  Diffusion tensor imaging detects retinal ganglion cell axon damage in the mouse model of optic nerve crush.

Authors:  Xu Zhang; Peng Sun; Jian Wang; Qing Wang; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

Review 3.  MR imaging of papilledema and visual pathways: effects of increased intracranial pressure and pathophysiologic mechanisms.

Authors:  N Passi; A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

4.  Voxel-based morphometry and diffusion tensor imaging of the optic pathway in primary open-angle glaucoma: a preliminary study.

Authors:  A K Zikou; G Kitsos; L C Tzarouchi; L Astrakas; G A Alexiou; M I Argyropoulou
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-24       Impact factor: 3.825

5.  Magnetic resonance diffusion tensor imaging and diffusion tensor tractography of human visual pathway.

Authors:  Yan Zhang; Si-Hai Wan; Gui-Jun Wu; Xue-Lin Zhang
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

6.  In vivo diffusion tensor imaging of amyloid-β-induced white matter damage in mice.

Authors:  Shu-Wei Sun; Hsiao-Fang Liang; Jennifer Mei; Dan Xu; Wei-Xing Shi
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

7.  Diffusion tensor imaging reveals visual pathway damage in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Christopher Nishioka; Christina Poh; Shu-Wei Sun
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 8.  Neuroimaging biomarkers of epileptogenesis.

Authors:  Asht Mangal Mishra; Harrison Bai; Alexandra Gribizis; Hal Blumenfeld
Journal:  Neurosci Lett       Date:  2011-02-16       Impact factor: 3.046

9.  DTI abnormalities in anterior corpus callosum of rats with spike-wave epilepsy.

Authors:  H Chahboune; A M Mishra; M N DeSalvo; L H Staib; M Purcaro; D Scheinost; X Papademetris; S J Fyson; M L Lorincz; V Crunelli; F Hyder; H Blumenfeld
Journal:  Neuroimage       Date:  2009-05-03       Impact factor: 6.556

10.  Optic nerve diffusion tensor imaging parameters and their correlation with optic disc topography and disease severity in adult glaucoma patients and controls.

Authors:  Sidney T Chang; Junqian Xu; Kathryn Trinkaus; Melike Pekmezci; Stella N Arthur; Sheng-Kwei Song; Edward M Barnett
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.